5月19日，诺瓦瓦克斯医药美股开盘上涨超过26%，创下两个月以来新高。此次股价上涨得益于美国食品药品监督管理局（FDA）批准其疫苗。这一进展提升了市场对其未来表现的信心。免责声明：本文内容由开放的智能模型自动生成，仅供参考。
Source Link5月19日，诺瓦瓦克斯医药美股开盘上涨超过26%，创下两个月以来新高。此次股价上涨得益于美国食品药品监督管理局（FDA）批准其疫苗。这一进展提升了市场对其未来表现的信心。免责声明：本文内容由开放的智能模型自动生成，仅供参考。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.